Journal article · 2021 · Open access
Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer
Frontiers in Oncology, 11, 705384 · Published 22 July 2021 · DOI 10.3389/fonc.2021.705384
In brief
“Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer” is a 2021 journal article by Willy Antoni Abreu de Oliveira and 11 co-authors, published in Frontiers in Oncology. OpenAlex counts 45 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Frontiers in Oncology.
- Citations
- 45
- Most cited in
- 2025 (11)
- Field-weighted impact
- 1.49
- References
- 99
- Authors
- 12
Abstract
Triple-Negative Breast Cancer (TNBC) is the most aggressive breast cancer subtype, characterized by limited treatment options and higher relapse rates than hormone-receptor-positive breast cancers. Chemotherapy remains the mainstay treatment for TNBC, and platinum salts have been explored as a therapeutic alternative in neo-adjuvant and metastatic settings. However, primary and acquired resistance to chemotherapy in general and platinum-based regimens specifically strongly hampers TNBC management. In this study, we used carboplatin-resistant in vivo patient-derived xenograft and isogenic TNBC cell-line models and detected enhanced Wnt/β-catenin activity correlating with an induced expression of stem cell markers in both resistant models. In accordance, the activation of canonical Wnt signaling in parental TNBC cell lines increases stem cell markers' expression, formation of tumorspheres and promotes carboplatin resistance. Finally, we prove that Wnt signaling inhibition resensitizes resistant models to carboplatin both in vitro and in vivo, suggesting the synergistic use of Wnt inhibitors and carboplatin as a therapeutic option in TNBC. Here we provide evidence for a prominent role of Wnt signaling in mediating resistance to carboplatin, and we establish that combinatorial targeting of Wnt signaling overcomes carboplatin resistance enhancing chemotherapeutic drug efficacy.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
de Oliveira, W. A. A., Moens, S., El Laithy, Y., van der Veer, B. K., Athanasouli, P., Cortesi, E. E., Baietti, M. F., Koh, K. P., Ventura, J., Amant, F. C., Annibali, D., & Lluís, F. (2021). Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer. Frontiers in Oncology, 11, 705384. https://doi.org/10.3389/fonc.2021.705384
MLA 9
de Oliveira, Willy Antoni Abreu, et al. “Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer.” Frontiers in Oncology, vol. 11, 2021, p. 705384. https://doi.org/10.3389/fonc.2021.705384.
Chicago
de Oliveira, Willy Antoni Abreu, Stijn Moens, Youssef El Laithy, Bernard K. van der Veer, Paraskevi Athanasouli, Emanuela Elsa Cortesi, Maria Francesca Baietti, et al. 2021. “Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer.” Frontiers in Oncology 11: 705384. https://doi.org/10.3389/fonc.2021.705384.
Harvard
de Oliveira, W. A. A. et al. (2021) ‘Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer’, Frontiers in Oncology, 11, p. 705384. doi:10.3389/fonc.2021.705384.
IEEE
W. A. A. de Oliveira et al., “Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer,” Frontiers in Oncology, vol. 11, p. 705384, 2021, doi: 10.3389/fonc.2021.705384.
BibTeX
@article{deoliveira2021catenin,
title = {{Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer}},
author = {de Oliveira, Willy Antoni Abreu and Moens, Stijn and El Laithy, Youssef and van der Veer, Bernard K. and Athanasouli, Paraskevi and Cortesi, Emanuela Elsa and Baietti, Maria Francesca and Koh, Kian Peng and Ventura, Juan‐José and Amant, Frédéric C. and Annibali, Daniela and Lluís, Frederic},
journal = {Frontiers in Oncology},
year = {2021},
volume = {11},
pages = {705384},
doi = {10.3389/fonc.2021.705384},
url = {https://doi.org/10.3389/fonc.2021.705384}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 1 | |
| 2022 | 7 | |
| 2023 | 10 | |
| 2024 | 6 | |
| 2025 | 11 | |
| 2026 | 9 |
Its field-weighted citation impact is 1.49: it has been cited 1.49 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- triple-negative breast cancer
- carboplatin resistance
- Wnt/β-catenin signaling
- Wnt inhibitors
- chemoresistance
- cancer stemness
- stem cell markers
- tumor spheres
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
de Oliveira, W. A. A., Moens, S., El Laithy, Y., van der Veer, B. K., Athanasouli, P., Cortesi, E. E., Baietti, M. F., Koh, K. P., Ventura, J., Amant, F. C., Annibali, D., & Lluís, F. (2021). Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer. Frontiers in Oncology, 11, 705384. https://doi.org/10.3389/fonc.2021.705384
How many times has this paper been cited?
45 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Oncology: sign in and open the full text from this page.
Who wrote this paper?
Willy Antoni Abreu de Oliveira, Stijn Moens, Youssef El Laithy, Bernard K. van der Veer, Paraskevi Athanasouli, Emanuela Elsa Cortesi, Maria Francesca Baietti, Kian Peng Koh, Juan‐José Ventura, Frédéric C. Amant, Daniela Annibali, Frederic Lluís.
What is the DOI of this paper?
10.3389/fonc.2021.705384, permanently at https://doi.org/10.3389/fonc.2021.705384. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.